↑Tan F, Morris PW, Skidgel RA, Erdos EG (setembro de 1993). "Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families". J Biol Chem268 (22): 16631–8. PMID8344943. doi:10.1016/S0021-9258(19)85465-0.
Odya CE, Marinkovic DV, Hammon KJ, et al. (1978). "Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney". J. Biol. Chem.253 (17): 5927–31. PMID28321. doi:10.1016/S0021-9258(17)34557-X.
Jackman HL, Tan F, Schraufnagel D, et al. (1995). "Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages". Am. J. Respir. Cell Mol. Biol.13 (2): 196–204. PMID7626287. doi:10.1165/ajrcmb.13.2.7626287.
Watson B, Nowak NJ, Myracle AD, et al. (1997). "The human angiotensinase C gene (HUMPCP) maps to 11q14 within 700 kb of D11S901: a candidate gene for essential hypertension". Genomics44 (3): 365–7. PMID9325062. doi:10.1006/geno.1997.4883.
Shariat-Madar Z, Mahdi F, Schmaier AH (2002). "Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator". J. Biol. Chem.277 (20): 17962–9. PMID11830581. doi:10.1074/jbc.M106101200.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet.36 (1): 40–5. PMID14702039. doi:10.1038/ng1285.